ContractNovation and Amendment Agreement • August 18th, 2021
Contract Type FiledAugust 18th, 2021Novation and Amendment AgreementThis Novation and Amendment Agreement (“Novation Agreement”) has been executed between: PARTIES (1) Celgene International II Sàrl, having its registered offices at Rue de Pré-Jorat 14, 2108 Couvet, Switzerland, including its Affiliates (“Outgoing Party” or “Celgene”)(2) Amgen Limited having its registered office at 240 Cambridge Science Park, Milton Road, Cambridge CB4 0WD, United Kingdom, including its Affiliates (“Incoming Party” or “Amgen”) (3) Fakultní nemocnice Plzeň, having an address at Edvarda Beneše 1128/13,305 99 Plzeň, Czech Republic, ID: 00669806, TIN: CZ00669806 (the “Participating Organisation”)(4) Kantar GmbH, a company incorporated under the laws of Germany, registered with company number DUNS 38-825- 3353, with registered office address at Landsberger Strasse 284, 80687 Munich, Germany (the “CRO”) Together Participating Organisation and CRO shall be collectively defined as the “Continuing Parties”The parties to this novation and amendmen